Cyclin-Dependent Kinase Inhibitor p15
"Cyclin-Dependent Kinase Inhibitor p15" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An INK4 cyclin-dependent kinase inhibitor containing four ANKYRIN-LIKE REPEATS. INK4B is often inactivated by deletions, mutations, or hypermethylation in HEMATOLOGIC NEOPLASMS.
| Descriptor ID |
D050762
|
| MeSH Number(s) |
D12.644.360.225.100 D12.776.167.187.100 D12.776.476.225.100 D12.776.624.776.355.100
|
| Concept/Terms |
Cyclin-Dependent Kinase Inhibitor p15- Cyclin-Dependent Kinase Inhibitor p15
- Cyclin Dependent Kinase Inhibitor p15
- INK4B Protein
- CDKN2B Protein
- INK4b Cyclin-Dependent Kinase Inhibitor
- INK4b Cyclin Dependent Kinase Inhibitor
- p15INK4B Protein
- p15 CDK4 Inhibitor
- CDK4 Inhibitor, p15
- Cyclin-Dependent Kinase Inhibitor 2B
- Cyclin Dependent Kinase Inhibitor 2B
|
Below are MeSH descriptors whose meaning is more general than "Cyclin-Dependent Kinase Inhibitor p15".
Below are MeSH descriptors whose meaning is more specific than "Cyclin-Dependent Kinase Inhibitor p15".
This graph shows the total number of publications written about "Cyclin-Dependent Kinase Inhibitor p15" by people in this website by year, and whether "Cyclin-Dependent Kinase Inhibitor p15" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclin-Dependent Kinase Inhibitor p15" by people in Profiles.
-
PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia. Leukemia. 2019 08; 33(8):1895-1909.
-
Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners. J Biol Chem. 2019 03 29; 294(13):4898-4910.
-
Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group. Clin Cancer Res. 2018 08 15; 24(16):3888-3897.
-
Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nat Commun. 2015 Jun 24; 6:7553.
-
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014 Oct; 16(10):1333-40.
-
Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia. J Natl Cancer Inst. 2014 Apr; 106(4):dju061.
-
Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013 May; 25(5):1086-95.
-
Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study. Circulation. 2013 Feb 19; 127(7):799-810.
-
Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012 Dec; 131(12):1877-88.
-
Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet. 2012 Feb 01; 5(1):100-12.